How pharma brands are marking #WorldAIDSDay

Many companies are taking the opportunity to share their progress or research towards finding a cure or developing treatments for the HIV and AIDS.

Pharma and medical brands are showing support to the HIV/AIDS community on World AIDS Day and looking forward to a cure for the disease, which affects 36.7 million people globally.

Pharma companies, which are on the front lines of developing treatments, are taking the opportunity to share their progress and research towards finding a cure or developing treatments.

The companies HIV/AIDS research and development programs, such as Gilead, Abbott, GlaxoSmithKline, Johnson & Johnson, and ViiV, an HIV-focused company formed by GSK and Pfizer, put together a history of their work towards curing the disease.

Examples include GSK and Abbot’s push to develop HIV treatments or ViiV’s partnerships with HIV organizations to reduce HIV transmission. Gilead is looking ahead, sharing its HIV partnership called HIV: The Long View, and anticipating what is next for HIV treatments and research. Johnson & Johnson created a dedicated World AIDS Day page, featuring interviews with scientists working on HIV treatments and with people living with HIV.

Here’s how several pharma brands are talking about their work on social media.

ViiV Healthcare



Gilead Sciences

Johnson & Johnson

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in

Would you like to post a comment?

Please Sign in or register.